The 2020 ISA Reference Edition is now available.
The Interoperability Standards Advisory (ISA) process represents the model by which the Office of the National Coordinator for Health Information Technology (ONC) will coordinate the identification, assessment, and public awareness of interoperability standards and implementation specifications that can be used by the United States healthcare industry to address specific interoperability needs including, but not limited to, interoperability for clinical, public health, and research purposes. ONC encourages all stakeholders to implement and use the standards and implementation specifications identified in the ISA as applicable to the specific interoperability needs they seek to address. Furthermore, ONC encourages further pilot testing and industry experience to be sought with respect to standards and implementation specifications identified as “emerging” in the ISA. For historical background on the ISA please review prior ISA publications.
The 2020 ISA has been updated to include improvements made based on recommendations received from public comments and subject matter expert feedback. To learn more about major revisions of the ISA, please review recent ISA updates. Registered users may subscribe to change notifications to be alerted by e-mail of all revisions to individual interoperability needs or for ISA-wide changes. Anyone may become a registered user by submitting an account request. Once logged in, look for the blue “change notification” button at the bottom of the interoperability need page, or at the bottom of the home page to be notified of any changes across the ISA. An RSS Feed was also added in 2018, capturing more granular updates made to the ISA.
Starting with the 2017 ISA, the ISA’s focus expanded to more explicitly include public health and health research interoperability. Thus, its scope includes electronic health information created in the context of treatment, and subsequently used to accomplish a purpose for which interoperability is needed (e.g., a referral to another care provider, public health reporting, or research). Added in late 2017, the ISA now also includes interoperability needs related to Administrative functions within healthcare. These additions were made through coordination with CMS, other administrative healthcare interoperability needs continue to be added.
The ISA is not exhaustive but it is expected to be incrementally updated to include a broader range of health IT interoperability needs. When more than one standard or implementation specification is listed it is intended to prompt industry dialogue as to whether one standard or implementation specification is necessary or if the industry can efficiently interoperate more than one. It may also reflect the fact that there is an ongoing transition from the use of one standard towards a new version or even a next-generation approach.
As noted in previous ISA publications, a standard listed in one section is not intended to imply that it would always be used or implemented independent of a standard in another section. To the contrary, it will often be necessary to combine the applicable standards from multiple sections to achieve interoperability for a particular clinical health information interoperability need.
It is also important to note that the ISA is designed to inform standards and implementation specification choices for all types of health IT that support interoperability needs, not solely electronic health record (EHR) systems. Furthermore, the ISA is not intended to imply that health IT systems need to support all of the listed standards and implementation specifications. Rather, in the event that a health IT developer or healthcare provider seeks to address a particular interoperability need, the ISA should serve as the first resource consulted to inform the selection of standards and implementation specifications. Additionally, the ISA is designed to inform the “what” that could be used to address an interoperability need in order to assure industry consistency around standards selection and is not mean to explicitly direct “how” the standards and implementation specifications would be implemented to address an interoperability need (e.g., application programming interface or conversion tools).
The ISA is designed to be a coordinated catalog of standards and implementation specifications that can be used by different stakeholders to consistently address a specific interoperability need. However, a listed interoperability need (and its associated standard(s) and implementation specifications(s)) is not meant to universally apply to all stakeholders. Rather, if a listed interoperability need is relevant to a particular clinical specialty, for example, the ISA is designed to provide a consistent foundation from which these stakeholders can agree on applicable technical requirements. Similarly, in cases where a listed interoperability need is not applicable to a given stakeholder group, the ISA in no way compels such stakeholders to consider that interoperability need.
Please note that the ISA serves as an informational resource for available standards, specifications, profiles, etc that exist to meet the interoperability needs contained within. Stakeholders should ensure and verify that they are adhering to applicable federal, state, and/or local laws or regulations regarding requirements to use a specific standard or specification that may conflict with the information listed in the ISA, as these requirements supersede the ISA.
The Interoperability Standards Advisory is meant to serve at least the following purposes:
- To provide the industry with a single, public list of standards and implementation specifications that can be used to address specific health information interoperability needs in the United States. Currently, the ISA is focused on interoperability for sharing information between entities and not on intra-organizational uses.
- To reflect the results of ongoing dialogue, debate, and consensus among industry stakeholders when more than one standard or implementation specification could be used to address a specific interoperability need, discussion will take place through the ISA public comments process. The web-version of the ISA improves upon existing processes, making comments more transparent, and allowing for threaded discussions to promote further dialogue.
- To document known limitations, preconditions, and dependencies as well as provide suggestions for security best practices in the form of security patterns for referenced standards and implementation specifications when they are used to address a specific clinical health IT interoperability need.
The ISA is designed to provide clarity, consistency, and predictability for the public regarding the standards and implementation specifications that could be used for a given clinical health IT interoperability purpose.
Stakeholders who administer government programs, procurements, and testing or certification programs with clinical health IT interoperability components are encouraged to look first to the ISA in order to more fully inform their goals. In that regard, standards and implementation specifications in the ISA and their associated informative characteristics are also available to help more fully inform policymaking. In this case, a standard or implementation specification’s reference in the ISA may serve as the initial basis for industry or government consideration and action. While the ISA itself is a non-binding document and meant to be advisory in nature, standards and implementation specifications listed in the ISA may be considered for rulemaking or other Federal requirements. However, those decisions would be made on a case-by-case basis by the administering organization.
This site contains numerous links to other federal agencies and to private organizations. You are subject to these sites’ privacy policies when you access them. HHS is not responsible for Section 508 compliance (accessibility) on other federal or private sites. HHS is not responsible for the contents of any "off-site" web page referenced from this site.
The ISA is organized and structured into four sections.
- Section I – Vocabulary/Code Sets/Terminology Standards and Implementation Specifications (i.e., “semantics”).
- Section II – Content/Structure Standards and Implementation Specifications (i.e., “syntax”).
- Section III – Standards and Implementation Specifications for Services (i.e., the infrastructure components deployed and used to address specific interoperability needs)
- Section IV – Administrative Standards and Implementation Specifications (i.e., payment, operations and other "non-clinical" interoperability needs)
- Questions and Requests for Stakeholder Feedback
- Appendices
Within each section specific “interoperability need” subheadings are listed and followed by tables similar to the one illustrated below. Each interoperability need may have one or more standards and/or implementation specifications associated with it. Each standard and implementation specification has six informative characteristics attributed to it in order to provide added context.
When known, an “emerging” standard or implementation specification is also listed and is shaded in a lighter color and italicized for additional emphasis. In addition, for vocabulary standards, where there may be one standard used to represent the “observation” or question being asked, and one standard used for the “observation value” or answer these are listed in distinct rows. See Appendix III for educational information about observations and observation values.
In Section I, the vocabulary standards with unspecified code sets or context may be further constrained by a more explicit standard named in a subsequent section. For example, Section I: Encounter Diagnoses specifies SNOMED-CT and ICD-10-CM but does not define the context of use. The Standard/Implementation Specification named for the “Interoperability Need: Ordering Labs for a Patient in Section II: Laboratory” further constrains the diagnosis for the patient in the context of a lab order to ICD-9CM or ICD-10CM since the lab order diagnosis is for billing/claims, not clinical diagnostics.
Standard Implementation/Specification | Standards Process Maturity | Implementation Maturity | Adoption Level | Federally Required | Cost | Test Tool Availability |
---|---|---|---|---|---|---|
Standard | Final | Production | No | Free | No | |
Standard for observations | Final | Production | Yes | Free | Yes | |
Standard for observation values | Final | Production | No | Free | Yes | |
Emerging Standard | Balloted Draft | Pilot | No | Free | No |
Limitations, Dependencies, and Preconditions for Consideration: |
Section I: Applicable Value Set(s) and Starter Set(s): Other Sections: Applicable Security Patterns for Consideration: |
---|---|
|
|
The following describes the ISA’s six informative characteristics in greater detail. This detail is meant to better inform stakeholders about the maturity and adoptability of a given standard or implementation specification and provides definition for the terms and symbols used throughout the ISA. Stakeholders should consider all six characteristics together to gain insight into the level of maturity and adoptability of the standards and implementation specifications provided within the ISA.
#1: Standards Process Maturity
This characteristic conveys a standard or implementation specification’s maturity in terms of its stage within a particular organization’s approval/voting process.
- “Final” – when this designation is assigned, the standard or implementation specification is considered “final text” or “normative” by the organization that maintains it. This also includes approved “ANSI Informative” specifications.
- “Balloted Draft” – when this designation is assigned, the standard or implementation specification is considered to be a Draft Standard for Trial Use (DSTU), Standard for Trial Use (STU), or in a “trial implementation” status by the organization that maintains it and has been voted on or approved by its membership as such. This designation does not include standards and implementation guides that are unofficial drafts and early “works in progress”.
- “In Development” – when this designation is assigned, the standard or implementation specification is currently in development. It also includes those that are in the midst of being balloted. These standards would generally benefit from lessons learned through development and pilots.
#2: Implementation Maturity
This characteristic conveys a standard or implementation specification’s maturity based upon its implementation state. Where available, a link to published maturity assessments based on known published criteria about the standards is also provided.
- “Production” – when this designation is assigned, the standard or implementation specification is being used in production to meet a health care interoperability need.
- “Pilot” – when this designation is assigned, the standard or implementation specification is being used on a limited scale or only as part of pilots to meet a health care interoperability need.
#3: Adoption Level
This characteristic conveys a standard or implementation specification’s approximate, average adoption level for that specific interoperability need in health care within the United States. The adoption level attempts to consider all implemented technology that would be used to address the identified interoperability need and is not limited to EHRs. Adoption means that the standard or implementation specification is being used in health IT in the field by end users to address the specific interoperability need. Presently, the adoption levels listed are based on ONC’s analysis of several factors, including, but not limited to: 1) whether and/or how long a standard or implementation specification has been included in regulation for health IT certification (if applicable) or another HHS regulatory or program requirement which is used only as a proxy for industry adoption; 2) feedback from subject matter experts and 3) public comments.
The adoption level also considers the variety of stakeholders and stakeholder groups that would use the standard and implementation specification to address the specified interoperability need and attempts to display it as such, with the understanding that the designation is a generality or "best guess" and not a pre-defined measured value. Where available, annotated references or links to publicly available documentation known about adoption levels for listed standards are also provided.
The following scale is used to indicate the approximate, average adoption level among the stakeholders that would use a standard or implementation specification to meet the specified interoperability need:
“Feedback Requested” | Indicates that we do not have a known status for the current level of adoption in health care. |
Indicates low adoption. | |
Indicates low-medium adoption. | |
Indicates medium adoption. | |
Indicates medium-high adoption. | |
Indicates high or widespread adoption. |
#4: Federally Required
This characteristic (provided as a “Yes” or “No”) conveys whether a standard or implementation specification has been adopted in regulation, referenced as a federal program requirement, or referenced in a federal procurement (i.e., contract or grant) for a particular interoperability need. Where available, a link to the regulation has been provided. Please note this is meant to be provided as a reference only. Entities seeking to comply with federal regulations should look to any and all federal regulations that may apply to ensure adequate compliance.
#5: Cost
This characteristic conveys whether a fee is involved to purchase, license, or obtain membership for access or use of the recommended standard or implementation specification.
- “$” – when this designation is assigned, it signifies that some type of payment needs to be made in order to obtain the standard or implementation specification. Where known, the estimated cost for access will be provided.
- “Free” – when this designation is assigned, it signifies that the standard or implementation specification can be obtained without cost. This designation applies even if a user account or license agreement is required to obtain the standard at no cost, but is not meant to imply that there are no costs associated with implementation.
#6: Test Tool Availability
This characteristic conveys whether a test tool is available to evaluate health IT’s conformance to the standard or implementation specification for the particular interoperability need. Where available, a link will be provided to the publicly available test tool.
- “Yes” – When this designation is assigned, it signifies that a test tool is available for a standard or implementation specification and is free to use. Where available, a hyperlink pointing to the test tool will be included.
- “Yes$”– When this designation is assigned, it signifies that a test tool is available for a standard or implementation specification and has a cost associated with its use. Where available, a hyperlink pointing to the test tool will be included.
- “Yes – Open” – When this designation is assigned, it signifies that a test tool is available for a standard or implementation specification and is available as open source with rights to modify. Where available, a hyperlink pointing to the test tool will be included.
- “No” – When this designation is assigned, it signifies that no test tool is available for a standard or implementation specification.
- “N/A” – When this designation is assigned, it signifies that a test tool for the standard or implementation would be “not applicable.”
Comment
Submitted by lvanhorn on
…
September 23, 2019
iShare Medical
3150 Mercier, Suite 608A
Kansas City, Missouri 64111
Donald Rucker, MD
National Coordinator for Health Information Technology
Office of the National Coordinator for Health Information Technology
Attention: ISA Comments
Dear Dr. Rucker:
On behalf of iShare Medical, we applaud the ONC for its determination to find a solution to the complex problem of trust in healthcare interoperability. We agree with the ONC that the use of common standards advances interoperability. Attached is a .pdf containing our comment.
Sincerely,
Linda Van Horn, MBA
Submitted by bgradl@eatright.org on
Academy of Nutrition and Dietetics comments on 2019 ISA
Thank you for allowing the Academy of Nutrition and Dietetics the opportunity to comment on the 2019 ISA. Attached is the Academy's comments.
Respectfully,
Becky Gradl
Academy of Nutrition and Dietetics -ISA Reply September 2019_0.pdf
Submitted by bgradl@eatright.org on
Academy of Nutrition and Dietetics comments on 2019 ISA
Thank you for allowing the Academy of Nutrition and Dietetic the opportunity to comment on the 2019 ISA. Attached are the comments from the Academy.
Respectfully,
Becky Gradl
Submitted by lpotter39 on
KP Comments on Draft 2019 ISA Annual Update
Please see attached comment letter.
Submitted by msaito on
Epic Comments on 2020 ISA Reference Edition
Thank you for the opportunity to provide feedback on the Interoperability Standards Advisory. Please see the attached documents with Epic's comments.
Submitted by swillis on
EHR Association Comments to the ONC 2019 ISA
On behalf of the 33 members of the HIMSS Electronic Health Record (EHR) Association, we are pleased to offer input on the 2019 Interoperability Standards Advisory (ISA).
EHR Association Comments to the ONC 2019 Interoperability Standards Advisory.pdf
Submitted by shellyspiro on
Pharmacy HIT Collaborative's Comments on ONC's Proposed 2019 ISA
Dear Sir or Madam:
On behalf of the membership of the Pharmacy Health Information Technology Collaborative (Collaborative), we are pleased to submit comments for the 2019 Interoperability Standards Advisory comment period.
The Collaborative has been involved with the federal agencies, including the Office of the National Coordinator (ONC), developing the national health information technology (HIT) framework since 2010. The Collaborative is supportive of the proposed standards for clinical health IT interoperability purposes.
Pharmacists provide patient-centered care and services, maintain various secure patient care records, and as part of the integrated health care team, they are directly involved with other health care providers and patients in various practice settings. Pharmacists are users of health IT and are especially supportive of interoperability standards incorporating HL7, SNOMED CT, LOINC, RxNorm, and NCPDP SCRIPT, and NCPDP Real Time Formulary and Benefits (currently under development). The Collaborative supports use of these particular standards which are important to pharmacists for documenting allergies (including medications, food, and environmental intolerances and reactions), immunizations (historical and administered), immunization registry reporting (query/response), medications, medication allergies, patient problems, smoking status, reporting to public health agencies, clinical decision support services/knowledge artifacts, drug formulary checking, and electronic prescribing (including new versions).
Attached are our comments regarding the 2019 Interoperability Standards Advisory.
Submitted by csnewman on
eLTSS as a standard for long term service and support exchange
Thank your for the opportunity to comment on the ISA. Long term services and support are critical to the well being and quality of life of millions of people receiving assistance in the community. It is essential to exchange clinical and care data (eg goals, required services, demographics, etc) between health care providers, service providers and care coordinators. HL7 has recently published a FHIR implementation guide (http://hl7.org/fhir/us/eltss/index.html) focused on data exchange in this area. We suggest that this IG be included in the ISA. The document is still an STU version and adoption level is low. It is not federally required but it is free and a reference implementation will be available shortly.
Submitted by jserchen@acpon… on
ACP Comments on ONC's 2019 ISA
Dear Dr. Rucker,
The College is pleased to submit the attached comments on the Office of the National Coordinator for Health Information Technology’s (ONC’s) 2019 Interoperability Standards Advisory (ISA).
Best,
Josh Serchen
Analyst, Regulatory Affairs
Governmental Affairs and Public Policy
American College of Physicians
Submitted by mbarbine on
Kinometrix Interoperability
Thank you for your consideration.